QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

 casi-pharmaceuticals-advances-anti-cd38-antibody-cid-103-to-next-dose-cohort-in-phase-1-itp-trial

- CID-103 is a potential best-in-class, clinical stage anti-CD38 monoclonal antibody- Safety profile observed in first four dos...

 hc-wainwright--co-reiterates-buy-on-casi-pharmaceuticals-maintains-4-price-target

HC Wainwright & Co. analyst Sean Lee reiterates CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and maintains $4 price tar...

 hc-wainwright--co-reiterates-buy-on-casi-pharmaceuticals-maintains-4-price-target

HC Wainwright & Co. analyst Sean Lee reiterates CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and maintains $4 price tar...

 casi-pharmaceuticals-q1-eps-069-misses-061-estimate-sales-624m-beat-610m-estimate

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate o...

 casi-pharmaceuticals-receives-nasdaq-non-compliance-notice-on-market-value-requirement

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical co...

 hc-wainwright--co-maintains-buy-on-casi-pharmaceuticals-lowers-price-target-to-4

HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and lowers the price target...

 casi-pharmaceuticals-receives-updated-20m-proposal-from-ceo-dr-wei-wu-he-to-acquire-cos-business-operations-in-china-and-asian-rights-to-certain-pipeline-products-with-special-committee-continuing-evaluation-of-the-proposed-transaction-and-strategic-alternatives

CASI Pharmaceuticals, Inc. (NASDAQ:CASI, ", CASI", ))), a Cayman incorporated biopharmaceutical company focused on deve...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION